Cargando…

Inhibition of Development of N, N′‐Dimethylhydrazine‐induced Rat Colonic Aberrant Crypt Foci by Pre, Post and Simultaneous Treatments with 24R,25‐Dihydroxyvitamin D(3)

It has recently been reported that new vitamin D(3) derivatives can exert inhibitory effects on colon carcinogenesis in rats. In the present study the chemopreventive potential of 24R,25‐dihydroxyvitamin D(3) (24ff,25(OH)(2)vitainin D(3)) was assessed in a murine model of colon carcinogenesis. In ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Salim, Elsayed I., Wanibuchi, Hideki, Taniyama, Tetsuhide, Yano, Yoshihisa, Morimura, Keiichirou, Yamamoto, Shinji, Otani, Shuzo, Nishizawa, Yoshiki, Morii, Hirotoshi, Fukushima, Shoji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 1997
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5921318/
https://www.ncbi.nlm.nih.gov/pubmed/9439680
http://dx.doi.org/10.1111/j.1349-7006.1997.tb00329.x
_version_ 1783317983146278912
author Salim, Elsayed I.
Wanibuchi, Hideki
Taniyama, Tetsuhide
Yano, Yoshihisa
Morimura, Keiichirou
Yamamoto, Shinji
Otani, Shuzo
Nishizawa, Yoshiki
Morii, Hirotoshi
Fukushima, Shoji
author_facet Salim, Elsayed I.
Wanibuchi, Hideki
Taniyama, Tetsuhide
Yano, Yoshihisa
Morimura, Keiichirou
Yamamoto, Shinji
Otani, Shuzo
Nishizawa, Yoshiki
Morii, Hirotoshi
Fukushima, Shoji
author_sort Salim, Elsayed I.
collection PubMed
description It has recently been reported that new vitamin D(3) derivatives can exert inhibitory effects on colon carcinogenesis in rats. In the present study the chemopreventive potential of 24R,25‐dihydroxyvitamin D(3) (24ff,25(OH)(2)vitainin D(3)) was assessed in a murine model of colon carcinogenesis. In experiment 1, male 6‐week‐old F344 rats were administered N(2)N‐dimethylhydrazme (DMH) 20 mg/kg s.c. once a week 4 times. The rats were fed 24R,25(OH)(2)vitaniin D(3) at 10 ppm in the diet prior to (pre), together with (simultaneous) or after (post) DMH treatment. Modifying effects were assessed using aberrant crypt foci (ACF), putative preneoplastic lesions, as the end point markers in this model of colon carcinogenesis. After 8 weeks, pre and more markedly simultaneous administration of 24R,25‐(OH)(2)vitamin D(3) was found to have reduced the total numbers of ACF and significantly inhibited the development of foci. After 16 weeks, numbers of foci with ≥4 crypts, which are more likely to progress to tumors, were significantly reduced. The most pronounced inhibition of ACF development was noted in rats fed the 24R,25(OH)(2)vitaniin D(3) after DMH administration. The reduction was particularly marked in the proximal colon. Blood levels of calcium were not significantly increased over the control levels in groups administered DMH and the vitamin. Immunohistochemical staining showed numbers of proliferating cell nuclear antigen‐positive cells to.be lower in the colonic epithelia of rats fed the vitamin D(3) metabolite than in the controls. In experiment 2, the effect of 24R,25‐(OH)(2)vitamin D(3) on the alterations in c‐fos, c‐myc and c‐jun oncogene expression in response to DMH administration was examined by northern blot analysis. The early increase in expression of ornithine decarboxylase (ODC) activity was not altered by 24R,25(OH)(2)vitamin D(3). The results suggest that 24R,25(OH)(2)vitamin D(3) is a cancer chemopreventive agent which may suppresses DMH induction of lesions and their subsequent development via an antiproliferative action.
format Online
Article
Text
id pubmed-5921318
institution National Center for Biotechnology Information
language English
publishDate 1997
publisher Blackwell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-59213182018-05-11 Inhibition of Development of N, N′‐Dimethylhydrazine‐induced Rat Colonic Aberrant Crypt Foci by Pre, Post and Simultaneous Treatments with 24R,25‐Dihydroxyvitamin D(3) Salim, Elsayed I. Wanibuchi, Hideki Taniyama, Tetsuhide Yano, Yoshihisa Morimura, Keiichirou Yamamoto, Shinji Otani, Shuzo Nishizawa, Yoshiki Morii, Hirotoshi Fukushima, Shoji Jpn J Cancer Res Article It has recently been reported that new vitamin D(3) derivatives can exert inhibitory effects on colon carcinogenesis in rats. In the present study the chemopreventive potential of 24R,25‐dihydroxyvitamin D(3) (24ff,25(OH)(2)vitainin D(3)) was assessed in a murine model of colon carcinogenesis. In experiment 1, male 6‐week‐old F344 rats were administered N(2)N‐dimethylhydrazme (DMH) 20 mg/kg s.c. once a week 4 times. The rats were fed 24R,25(OH)(2)vitaniin D(3) at 10 ppm in the diet prior to (pre), together with (simultaneous) or after (post) DMH treatment. Modifying effects were assessed using aberrant crypt foci (ACF), putative preneoplastic lesions, as the end point markers in this model of colon carcinogenesis. After 8 weeks, pre and more markedly simultaneous administration of 24R,25‐(OH)(2)vitamin D(3) was found to have reduced the total numbers of ACF and significantly inhibited the development of foci. After 16 weeks, numbers of foci with ≥4 crypts, which are more likely to progress to tumors, were significantly reduced. The most pronounced inhibition of ACF development was noted in rats fed the 24R,25(OH)(2)vitaniin D(3) after DMH administration. The reduction was particularly marked in the proximal colon. Blood levels of calcium were not significantly increased over the control levels in groups administered DMH and the vitamin. Immunohistochemical staining showed numbers of proliferating cell nuclear antigen‐positive cells to.be lower in the colonic epithelia of rats fed the vitamin D(3) metabolite than in the controls. In experiment 2, the effect of 24R,25‐(OH)(2)vitamin D(3) on the alterations in c‐fos, c‐myc and c‐jun oncogene expression in response to DMH administration was examined by northern blot analysis. The early increase in expression of ornithine decarboxylase (ODC) activity was not altered by 24R,25(OH)(2)vitamin D(3). The results suggest that 24R,25(OH)(2)vitamin D(3) is a cancer chemopreventive agent which may suppresses DMH induction of lesions and their subsequent development via an antiproliferative action. Blackwell Publishing Ltd 1997-11 /pmc/articles/PMC5921318/ /pubmed/9439680 http://dx.doi.org/10.1111/j.1349-7006.1997.tb00329.x Text en
spellingShingle Article
Salim, Elsayed I.
Wanibuchi, Hideki
Taniyama, Tetsuhide
Yano, Yoshihisa
Morimura, Keiichirou
Yamamoto, Shinji
Otani, Shuzo
Nishizawa, Yoshiki
Morii, Hirotoshi
Fukushima, Shoji
Inhibition of Development of N, N′‐Dimethylhydrazine‐induced Rat Colonic Aberrant Crypt Foci by Pre, Post and Simultaneous Treatments with 24R,25‐Dihydroxyvitamin D(3)
title Inhibition of Development of N, N′‐Dimethylhydrazine‐induced Rat Colonic Aberrant Crypt Foci by Pre, Post and Simultaneous Treatments with 24R,25‐Dihydroxyvitamin D(3)
title_full Inhibition of Development of N, N′‐Dimethylhydrazine‐induced Rat Colonic Aberrant Crypt Foci by Pre, Post and Simultaneous Treatments with 24R,25‐Dihydroxyvitamin D(3)
title_fullStr Inhibition of Development of N, N′‐Dimethylhydrazine‐induced Rat Colonic Aberrant Crypt Foci by Pre, Post and Simultaneous Treatments with 24R,25‐Dihydroxyvitamin D(3)
title_full_unstemmed Inhibition of Development of N, N′‐Dimethylhydrazine‐induced Rat Colonic Aberrant Crypt Foci by Pre, Post and Simultaneous Treatments with 24R,25‐Dihydroxyvitamin D(3)
title_short Inhibition of Development of N, N′‐Dimethylhydrazine‐induced Rat Colonic Aberrant Crypt Foci by Pre, Post and Simultaneous Treatments with 24R,25‐Dihydroxyvitamin D(3)
title_sort inhibition of development of n, n′‐dimethylhydrazine‐induced rat colonic aberrant crypt foci by pre, post and simultaneous treatments with 24r,25‐dihydroxyvitamin d(3)
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5921318/
https://www.ncbi.nlm.nih.gov/pubmed/9439680
http://dx.doi.org/10.1111/j.1349-7006.1997.tb00329.x
work_keys_str_mv AT salimelsayedi inhibitionofdevelopmentofnndimethylhydrazineinducedratcolonicaberrantcryptfocibyprepostandsimultaneoustreatmentswith24r25dihydroxyvitamind3
AT wanibuchihideki inhibitionofdevelopmentofnndimethylhydrazineinducedratcolonicaberrantcryptfocibyprepostandsimultaneoustreatmentswith24r25dihydroxyvitamind3
AT taniyamatetsuhide inhibitionofdevelopmentofnndimethylhydrazineinducedratcolonicaberrantcryptfocibyprepostandsimultaneoustreatmentswith24r25dihydroxyvitamind3
AT yanoyoshihisa inhibitionofdevelopmentofnndimethylhydrazineinducedratcolonicaberrantcryptfocibyprepostandsimultaneoustreatmentswith24r25dihydroxyvitamind3
AT morimurakeiichirou inhibitionofdevelopmentofnndimethylhydrazineinducedratcolonicaberrantcryptfocibyprepostandsimultaneoustreatmentswith24r25dihydroxyvitamind3
AT yamamotoshinji inhibitionofdevelopmentofnndimethylhydrazineinducedratcolonicaberrantcryptfocibyprepostandsimultaneoustreatmentswith24r25dihydroxyvitamind3
AT otanishuzo inhibitionofdevelopmentofnndimethylhydrazineinducedratcolonicaberrantcryptfocibyprepostandsimultaneoustreatmentswith24r25dihydroxyvitamind3
AT nishizawayoshiki inhibitionofdevelopmentofnndimethylhydrazineinducedratcolonicaberrantcryptfocibyprepostandsimultaneoustreatmentswith24r25dihydroxyvitamind3
AT moriihirotoshi inhibitionofdevelopmentofnndimethylhydrazineinducedratcolonicaberrantcryptfocibyprepostandsimultaneoustreatmentswith24r25dihydroxyvitamind3
AT fukushimashoji inhibitionofdevelopmentofnndimethylhydrazineinducedratcolonicaberrantcryptfocibyprepostandsimultaneoustreatmentswith24r25dihydroxyvitamind3